Genetic modification will be tested for the first time in Europe to cure blood disorder

Scientists at Swiss company Crispr Therapeutics are hoping to use genetic modification to cure â-thalassemia, a devastating inherited blood disorder.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news